#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Asthma Dermatitis atopic Dementia Alzheimer's type Type 2 diabetes mellitus Breast cancer metastatic Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Anal cancer Bronchiolitis PIK3CA-activated mutation Angiosarcoma non-metastatic NTRK gene fusion overexpression Uterine leiomyosarcoma Toxic epidermal necrolysis Cutaneous T-cell lymphoma stage II Chronic graft versus host disease High-grade B-cell lymphoma Haemophilia A without inhibitors Oesophageal squamous cell carcinoma Idiopathic inflammatory myopathy Autoimmune hepatitis Adrenoleukodystrophy More trials…

    Learn about Rare Diseases

    Haemophagocytic lymphohistiocytosis – Diagnostics Adrenocortical carcinoma Familial haemophagocytic lymphohistiocytosis – Basic Information Lymphangiosarcoma – Basic Information Marginal zone lymphoma refractory – Diagnostics Hereditary neuropathic amyloidosis – Life with Disease Rhabdomyosarcoma – Diagnostics Biotinidase deficiency – Treatment Turner’s syndrome – Treatment Kearns-Sayre syndrome More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Tisagenlecleucel Lithium Sulphate, Anhydrous Human Coagulation Factor Viii Oditrasertib Defactinib Etoricoxib Atorvastatin Calcium Clopidogrel Hydrogen Sulfate Glyceryl Trinitrate Bi 1819479 Perindopril Arginine Fadraciclib Fluoxetine Soya Oil Sodium Acetate Trihydrate Dazukibart Betula Pendula Pollen Extract Eptinezumab ALFENTANIL HYDROCHLORIDE Naproxen More therapies…

    Learn about Your Condition

    Escherichia infection Multiple sclerosis Biotinidase deficiency Diabetic foot infection Guttate psoriasis ROHHAD syndrome Nodal osteoarthritis Tonsillitis EGFR gene mutation Precocious puberty Peripheral artery thrombosis Colitis Somatic symptom disorder Weaning failure Catatonia More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Hippokration Hospital

Hippokration Hospital

Konstadinoupoleos 49, Athens, 546 42, Greece

Want to learn more about this study or check if you can participate? Contact us.

  • A study testing cagrilintide and semaglutide combination for kidney damage in people with chronic kidney disease and type 2 diabetes who are overweight or obese

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Chronic kidney disease
    • Type 2 diabetes mellitus
    • Obesity
    Investigated Drugs:
    • Dapagliflozin Propanediol
    • Finerenone
    • Cagrilintide
    France Greece Hungary Poland Slovakia Spain

  • A study comparing cagrilintide and semaglutide combination to semaglutide, cagrilintide, and placebo in adults with type 2 diabetes on metformin

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Type 2 diabetes mellitus
    Investigated Drugs:
    • Metformin
    • Cagrilintide
    • Dapagliflozin
    Bulgaria Croatia Czechia Denmark Finland Germany +9

  • A study of ziltivekimab compared to placebo in people with heart and blood vessel disease, chronic kidney disease and inflammation

    Not recruiting

    3 1
    Investigated Diseases:
    • Chronic kidney disease
    • Arteriosclerosis
    Investigated Drugs:
    • Ziltivekimab
    Belgium Bulgaria Croatia Czechia Denmark Germany +12

  • A study of ziltivekimab compared to placebo for reducing heart problems in patients who have had a heart attack

    Not recruiting

    3 1
    Investigated Diseases:
    • Acute myocardial infarction
    Investigated Drugs:
    • Ziltivekimab
    Bulgaria Czechia Denmark France Germany Greece +4

  • A study comparing ziltivekimab to placebo in patients with heart failure with mildly reduced or preserved ejection fraction and inflammation

    Not recruiting

    3 1
    Investigated Drugs:
    • Ziltivekimab
    Austria Belgium Bulgaria Croatia Czechia Denmark +18

  • Comparing bemnifosbuvir-ruzasvir and sofosbuvir-velpatasvir for treatment of chronic hepatitis C virus infection in adult patients

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Ruzasvir
    • SOFOSBUVIR
    • VELPATASVIR
    France Germany Greece Poland Romania Spain

  • Study on the Safety and Immune Response of a 21-Valent Pneumococcal Conjugate Vaccine in Healthy Infants and Toddlers

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Pneumococcal Polysaccharide Serotype 1
    • Pneumococcal Polysaccharide Serotype 10A
    • Pneumococcal Polysaccharide Serotype 11A
    Belgium Czechia Estonia Finland Germany Greece +3

  • Study on the Safety and Effectiveness of Clesrovimab and Palivizumab for Preventing Severe RSV in Infants and Children at High Risk

    Not recruiting

    3 1 1
    Investigated Drugs:
    • CLESROVIMAB
    • Palivizumab
    • Sodium Chloride
    Czechia Finland France Germany Greece Hungary +3

  • Study of cannabidiol (CardiolRx) in patients with recurrent pericarditis after stopping IL-1 blocker treatment

    Not recruiting

    3 1
    Investigated Drugs:
    • Cannabidiol
    Greece Italy

  • Study on the Effect of Survodutide on Heart Safety in Patients with Obesity and Cardiovascular or Kidney Disease

    Not recruiting

    3 1
    Investigated Drugs:
    • BI 456906
    • SURVODUTIDE
    Austria Belgium Bulgaria Czechia Denmark Finland +11
Previous Page
1 … 6 7 8 9 10 … 14
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!